Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALLIANCE PHARMA PLC Board/Management Information 2015

Jan 26, 2015

7478_rns_2015-01-26_e286433f-81dc-4059-a4e1-c7d0fc711aa4.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0888D

Alliance Pharma PLC

26 January 2015

For immediate release 26 January 2015

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Appointment of Non-Executive Director

Alliance Pharma plc ("Alliance" or the "Company") is pleased to announce the appointment of Nigel Clifford as an independent Non-Executive Director of the Company. Nigel will join the Board with immediate effect.

Nigel is Chief Executive of Procserve Holdings Limited, a leading company in enabling secure transactions online. He is also currently a non-executive director of Anite plc.   He has previously held senior positions at Micro Focus International plc, Nokia, Symbian Software Ltd, Tertio Telecoms Limited, Cable and Wireless plc, Glasgow Royal Infirmary NHS Trust and BT plc.

Commenting on the appointment, Andrew Smith, Chairman of Alliance, said:

"We are delighted to welcome Nigel to the Board of Alliance. His breadth of business experience and his significant exposure to international and European markets make him a strong addition to the Alliance team."

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies. Nigel Richard Clifford, aged 55 years, has been a director of the following companies during the five years preceding the date of this announcement:

Current directorships Past Directorships
Anite plc Symbian Limited
Procserve Holdings Limited Symbian Software Limited
Procserve Services Limited Micro Focus International plc
Procserve Shared Services Limited
Procserve Solutions Limited
Procserve Supplier Solutions Limited

There is no further information to be disclosed pursuant to Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

For further information:

### Alliance Pharma plc ### + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
### Buchanan ### + 44 (0) 20 7466 5000
Mark Court / Sophie Cowles
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Freddie Barnfield
Corporate Broking: David Poutney

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOADBGDBISDBGUU